New Haven, CT, United States of America

Lawrence R Marcin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biohaven Therapeutics Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence R Marcin. Retrieved from https://idiyas.com/inventor/lawrence-r-marcin-ju48s1la

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lawrence R. Marcin

Introduction

Lawrence R. Marcin is an accomplished inventor based in New Haven, CT (US). He has made significant contributions to the field of immunology through his innovative work. His expertise is reflected in his patent, which addresses critical advancements in the treatment of immunoglobulin deficiencies.

Latest Patents

Marcin holds a patent for "Bifunctional Degraders of Galactose-Deficient Immunoglobulins." This invention represents a breakthrough in the development of therapies aimed at improving immune responses in patients with specific immunological conditions. His work in this area has the potential to enhance treatment options and patient outcomes.

Career Highlights

Throughout his career, Marcin has been associated with Biohaven Therapeutics Ltd., a company known for its focus on innovative therapies. His role at Biohaven has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Marcin has worked alongside notable colleagues, including Reese M. Caldwell and Gene M. Dubowchik. These collaborations have fostered a dynamic environment for innovation and have led to advancements in therapeutic strategies.

Conclusion

Lawrence R. Marcin's contributions to immunology through his patent and work at Biohaven Therapeutics Ltd. highlight his role as a key innovator in the field. His efforts continue to pave the way for new treatments that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…